The Latest in Global Clinical Transparency and Disclosure
Transparent Thinking Blog
FDA Issues its First Action for Non-Compliance with ClinicalTrials.Gov FDAAA Section 801 RequirementsRead More
Certara Adopts TrialAssure ANONYMIZE Solution to Speed Life Science Industry Need to Meet Regulatory Requirements for Data SharingRead More
Clinical Trial Transparency Research & Guidance
White Paper: Pharmaceutical Industry Challenges Facing Clinical Trial Disclosure and Transparency
New regulations set to take effect in 2021 will dramatically change how sponsors report clinical trial data. Overall, the current regulations in both the EU/European Economic Area (EEA) and the US require the registration of new clinical trials and the posting of summary results for all completed studies, regardless of the approval status of the medicinal products. Download the white paper below to learn how to adapt to the new and changing clinical trial disclosure and transparency requirements, allowing your organization to be at the forefront of change.
Upcoming Webinar Announced
Join us this June (exact date TBD) for our upcoming webinar titled, How to effectively implement an end-to-end disclosure and transparency strategy and governance. Register now!